Category: Pharmaceuticals
North America Pharmaceuticals
-
Cognitive Computing
... CAGR of 27.6% over the analysis period 2024-2030. Natural Language Processing Technology, one of the segments analyzed in the report, is expected to record a 25.1% CAGR and reach US$159.0 Billion by the end of ... Read More
-
Coronary Artery Bypass Grafts (CABG)
... Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Off-Pump CABG, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$109.1 Million ... Read More
-
Internet Ad Spending
... at a CAGR of 7.8% over the analysis period 2024-2030. Search Advertising, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$214.9 Billion by the end of ... Read More
-
Medication Management Systems
... at a CAGR of 9.9% over the analysis period 2024-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion by the end ... Read More
-
Hydroponics
... 14.2% over the analysis period 2024-2030. Tomatoes Crop, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth ... Read More
-
Pectin
... 5.0% over the analysis period 2024-2030. Food & BeverageEnd-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$904.0 Million by the end of the analysis period. ... Read More
-
Counter Terror and Public Safety Technology
... reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Cyber Security Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and ... Read More
-
Healthcare Cleanroom Consumables
... at a CAGR of 4.8% over the analysis period 2024-2030. Cleanroom Apparel, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.7 Billion by the end of ... Read More
-
Coenzyme Q10
... CAGR of 4.5% over the analysis period 2024-2030. Dietary Supplements Application, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$609.1 Million by the end of the ... Read More
-
Krill Oil
... CAGR of 10.1% over the analysis period 2024-2030. Krill Oil Softgels, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$485.1 Million by the end of the ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Books
... 2.9% over the analysis period 2024-2030. Mystery Books, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$35.4 Billion by the end of the analysis period. Growth ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Urgent Care Center
... at a CAGR of 6.0% over the analysis period 2024-2030. Trauma / Injury Treatment Service, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$12.2 Billion by ... Read More
-
North America Halal Pharmaceuticals Market Forecast 2025-2032
... forecasting years are from 2025 to 2032. MARKET INSIGHTS The North American halal certified pharmaceuticals market is experiencing significant growth, driven by the rising demand for ethical and compliant healthcare solutions. This growth is supported ... Read More
-
The U.S. Medical Weight Loss Market: The Impact of GLP-1s On Doctors, Hospitals, Clinics and Franchises
... There are no medical associations or private sector research firms that cover the small and privately-owned medical weight loss chains, franchises, hospitals and clinics. Marketdata has filled in the gaps with extensive primary research. The ... Read More
-
Hybrid and Electric Vehicle Fuses
... Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2024-2030. Hybrid Electric Vehicles (HEVs) Application, one of the segments analyzed in the report, is expected to record a 25.2% CAGR and ... Read More
-
Home Care Services
... at a CAGR of 7.3% over the analysis period 2024-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.7 Billion by the end of ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Personal Finance Software
... at a CAGR of 5.0% over the analysis period 2024-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by the end of ... Read More
-
Online Home Rental Services
... 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Flats Rental Services, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$40.3 Billion by ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More
Research Assistance
